Pegvaliase
- Part D specialty tier in 73% of formularies (2026Q3)
- Biologic
- Palynziq
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Pegvaliase: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store in refrigerator at 36°F to 46°F (2°C to 8°C) in its original carton to protect from light.
- Freezing
- Do not freeze
Label statement
Do not freeze or shake.
- Room temperature
- up to 30 days at or below 25°C (77°F)
Label statement
For patients : If needed, store PALYNZIQ in the original carton at room temperature between 68°F to 77°F (20°C to 25°C) for up to 30 days.
- Room temperature
- up to 30 days
Label statement
The shelf-life expires after storage at room temperature for 30 days, or after the expiration date on the product carton, whichever is earlier.
- Back into the refrigerator
- Not allowed
Label statement
Once stored at room temperature, do not return the product to the refrigerator.
- Light
- Protect from light
Label statement
Store in refrigerator at 36°F to 46°F (2°C to 8°C) in its original carton to protect from light.
- Shaking
- Not addressed
All storage statements on the label (6)
- Store in refrigerator at 36°F to 46°F (2°C to 8°C) in its original carton to protect from light.
- Do not freeze or shake.
- For patients : If needed, store PALYNZIQ in the original carton at room temperature between 68°F to 77°F (20°C to 25°C) for up to 30 days.
- Record the date removed from refrigeration on the carton.
- Once stored at room temperature, do not return the product to the refrigerator.
- The shelf-life expires after storage at room temperature for 30 days, or after the expiration date on the product carton, whichever is earlier.
FDA label version 36, effective March 2, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.